M30.3 Mucocutaneous lymph node syndrome [Kawasaki]

Name of the Condition

• Mucocutaneous lymph node syndrome [Kawasaki]

Summary

Mucocutaneous lymph node syndrome, also known as Kawasaki disease, is an acute febrile vasculitis primarily affecting children. It involves inflammation of medium-sized blood vessels, particularly the coronary arteries, and is characterized by a combination of clinical features including fever, rash, mucosal changes, and lymphadenopathy. The condition can lead to serious cardiac complications if not treated promptly.

Causes

The exact cause of mucocutaneous lymph node syndrome is unknown, but it is thought to involve an abnormal immune response triggered by an infectious or environmental agent. The condition is not contagious, and no single pathogen has been definitively identified as the cause. Genetic factors may also play a role in susceptibility.

Risk Factors

• Age: Most common in children under 5 years old, with peak incidence between 1 and 2 years.
• Ethnicity: Higher prevalence in Asian populations, particularly those of Japanese descent.
• Seasonality: Slight increase in cases during winter and spring.
• No known gender predisposition (affects boys and girls equally).

Symptoms

• Fever: Persistent high fever lasting 5 or more days, unresponsive to antibiotics.
• Rash: Polymorphous, non-vesicular rash on the trunk and extremities.
• Mucosal changes: Red, cracked lips; strawberry tongue; and erythema of the oropharynx.
• Lymphadenopathy: Swollen cervical lymph nodes (at least one node >1.5 cm).
• Extremity changes: Edema and erythema of the hands/feet, followed by desquamation.
• Ocular involvement: Non-exudative conjunctivitis.

Diagnosis

Diagnosis is based on clinical criteria, including fever lasting ≥5 days plus at least four of the five principal features (rash, mucosal changes, lymphadenopathy, extremity changes, ocular involvement). Laboratory tests may show elevated inflammatory markers, thrombocytosis, and hyponatremia. Echocardiography is used to assess for coronary artery abnormalities.

Treatment Options

• Intravenous immunoglobulin (IVIG): First-line therapy to reduce inflammation and prevent coronary complications.
• Aspirin: Used for anti-inflammatory and antiplatelet effects, adjusted based on clinical response.
• Corticosteroids: Considered in refractory cases or when IVIG is contraindicated.
• Supportive care: Management of fever, hydration, and monitoring for complications.

Prognosis and Follow-Up

With early treatment, most children recover fully. However, 20–25% of untreated cases develop coronary artery aneurysms. Long-term follow-up with echocardiography is recommended to monitor for late cardiac complications. Prognosis is generally good with appropriate management.

Complications

• Coronary artery aneurysms: The most serious complication, potentially leading to myocardial infarction or sudden death.
• Valvular heart disease: Rare but possible long-term sequelae.
• Gallbladder hydrops: Occurs in some cases.
• Arthritis or arthralgia: May persist during the acute phase.

Lifestyle & Prevention

• No specific preventive measures are known, as the cause is unclear.
• Hygiene practices: General infection control may reduce exposure to potential triggers.
• Vaccination: Ensure up-to-date immunizations, as some live vaccines are contraindicated during acute illness.

When to Seek Professional Help

Seek immediate medical attention if a child has a persistent fever lasting >3 days with any of the characteristic symptoms (rash, red lips, swollen lymph nodes, or extremity changes). Early diagnosis and treatment are critical to prevent cardiac complications.

Tips for Medical Coders

• Code M30.3 is specific to mucocutaneous lymph node syndrome (Kawasaki disease) and should be used when the diagnosis is confirmed by clinical criteria.
• Documentation considerations: Ensure the medical record includes details of fever duration, presence of at least four principal features, and any cardiac evaluations (e.g., echocardiogram results). Avoid using this code for incomplete or atypical presentations without clear diagnostic confirmation.